LINC00470 promotes tumour proliferation and invasion, and attenuates chemosensitivity through the LINC00470/miR‐134/Myc/ABCC1 axis in glioma

Overexpression of the phospholipase A2 group V gene in glioma tumors is associated with poor patient prognosis

(2019) Changwu Wu et al.   Cancer Management and Research

A cytoplasmic long noncoding RNA LINC00470 as a new AKT activator to mediate glioblastoma cell autophagy

(2018) Changhong Liu et al.   Journal of Hematology & Oncology

LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway

(2017) Yiwei Liao et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Long non-coding RNA in glioma: signaling pathways

(2017) Jia Shi et al.   Oncotarget

miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor

(2016) Qin Qin et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

MicroRNA-134 modulates glioma cell U251 proliferation and invasion by targeting KRAS and suppressing the ERK pathway

(2016) Yuguang Zhao et al.   TUMOR BIOLOGY

Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1

(2016) Cheng-Cao Sun et al.   Oncotarget

Myc and its interactors take shape

(2015) William B. Tu et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

miR-134 Functions as a Tumor Suppressor in Cell Proliferation and Epithelial-to-Mesenchymal Transition by Targeting KRAS in Renal Cell Carcinoma Cells

(2015) Yiyang Liu et al.   DNA AND CELL BIOLOGY

Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide

(2015) Khaled Messaoudi et al.   DRUG DISCOVERY TODAY

Reduced expression of microRNA-134 correlates with malignancy and poor prognosis in human glioma

(2015) Jianfeng Zhong et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme

(2015) Amanda Tivnan et al.   Frontiers in Neuroscience

Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B and glioblastoma

(2014) Y Zhang et al.   CELL DEATH AND DIFFERENTIATION

MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins

(2014) Yongtao Gao et al.   FEBS LETTERS

Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis

(2014) Daniela Annibali et al.   Nature Communications

Impact of MYC on malignant behavior

(2014) G. Ott   Hematology-American Society of Hematology Education Program

An emerging role for long non-coding RNAs in cancer metastasis

(2014) Jason T. Serviss et al.   Frontiers in Genetics

Nanomedicine therapeutic approaches to overcome cancer drug resistance

(2013) Janet L. Markman et al.   ADVANCED DRUG DELIVERY REVIEWS

Targeting Multidrug Resistance Protein 1 (MRP1, ABCC1): Past, Present, and Future

(2013) Susan P.C. Cole   Annual Review of Pharmacology and Toxicology

MiR-134 regulates the proliferation and invasion of glioblastoma cells by reducing Nanog expression

(2013) CHAO SHI NIU et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Glioblastoma management in the temozolomide era: have we improved outcome?

(2013) Zarnie Lwin et al.   JOURNAL OF NEURO-ONCOLOGY

Pan-cancer patterns of somatic copy number alteration

(2013) Travis I Zack et al.   NATURE GENETICS

Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma

(2013) Tomohiro Yamaki et al.   Scientific Reports

MYC on the Path to Cancer

(2012) Chi V. Dang   CELL

Primary brain tumours in adults

(2012) Damien Ricard et al.   LANCET

Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology

(2012) Xue Xue et al.   Chinese Journal of Cancer

Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide

(2011) G. Prasad et al.   NEURO-ONCOLOGY

Emerging Roles for Natural MicroRNA Sponges

(2010) Margaret S. Ebert et al.   CURRENT BIOLOGY

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

miR-24 Inhibits Cell Proliferation by Targeting E2F2, MYC, and Other Cell-Cycle Genes via Binding to “Seedless” 3′UTR MicroRNA Recognition Elements

(2009) Ashish Lal et al.   MOLECULAR CELL

Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts

(2009) J. Graeme Hodgson et al.   NEURO-ONCOLOGY

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

(2009) M. G. Vander Heiden et al.   SCIENCE

c -MYC amplification and expression in astrocytic tumors

(2008) Mário Henrique Faria et al.   ACTA NEUROPATHOLOGICA